Skip to main content
. 2017 Apr 16;9(6):387–404. doi: 10.1177/1758834017702820

Figure 1.

Figure 1.

Developmental program of osimertinib.

EMA, European Medicines Agency; US FDA, United States Food and Drug Administration.